Puerarin 6''‑O‑xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis

Zhang,Xiao‑Lan; Wang,Bin‑Bin; Mo,Jian‑Shu

doi:10.3892/ol.2018.9364

Puerarin 6''‑O‑xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis

Authors:
- Xiao‑Lan Zhang
- Bin‑Bin Wang
- Jian‑Shu Mo
View Affiliations

Affiliations: Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China, Department of Oncology, Cixi City Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang 315300, P.R. China
Published online on: August 24, 2018 https://doi.org/10.3892/ol.2018.9364
Pages: 5557-5564
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Puerarin 6''‑O‑xyloside (PRX) is a major compound found in the root of the Pueraria lobata (Willd.) Ohwi. The present study aimed to investigate the antitumor activity of PRX against colon cancer and examine its possible mechanism. In the present study, the anti‑proliferative effects of PRX against colon cell lines (SW480, LoVo and HCT‑116) were evaluated using a Cell Counting Kit‑8 assay, and the half maximal inhibitory concentration values of the SW480, LoVo and HCT‑11 cells were 37.114, 49.213 and 43.022 µg/ml, respectively. Furthermore, the apoptosis of SW480 cells was detected using flow cytometry with Annexin V‑fluorescein isothiocyanate/propidium iodide staining. Subsequently, western blot analysis was performed to examine the expression of proteins associated with apoptosis, invasion and metastasis of tumors. The results showed that PRX possessed antitumor activity against colon cancer cell lines in a dose‑dependent and time‑dependent manner. In addition, PRX significantly upregulated the expression levels of cleaved (c)‑caspase‑3, c‑caspase‑9, B‑cell lymphoma 2 (Bcl‑2), Bcl‑2‑associated X protein and phosphorylated c‑Jun terminal kinase, and downregulated the expression levels of Bcl‑2, matrix metalloproteinase (MMP)‑3, MMP‑9 and vascular endothelial growth factor (P<0.01). Therefore, the present study demonstrated the PRX exerted antitumor activity against colon cancer cell lines and that the anticancer mechanisms of PRX may be associated with the induction of mitochondria‑mediated intrinsic apoptosis, and inhibition of tumor invasion and metastasis. The present study provides a scientific basis for the clinical use of PRX for the treatment of colon cancer.

View Figures

View References

1	Global Burden of Disease Cancer Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et al: The Global Burden of Cancer 2013. JAMA Oncol. 1:505–527. 2015. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
4	Daaboul HE, Daher CF, Bodman-Smith K, Taleb RI, Shebaby WN, Boulos J, Dagher C, Mroueh MA and El-Sibai M: Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways. Chem Biol Interact. 275:162–172. 2017. View Article : Google Scholar : PubMed/NCBI
5	Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005. View Article : Google Scholar : PubMed/NCBI
6	Chen R, Xue J and Xie M: Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression. J Nutr Biochem. 23:1080–1085. 2012. View Article : Google Scholar : PubMed/NCBI
7	Zhou YX, Zhang H and Peng C: Puerarin: A review of pharmacological effects. Phytother Res. 28:961–975. 2014. View Article : Google Scholar : PubMed/NCBI
8	Wang Q, Wu T, Chen X, Ni J, Duan X, Zheng J, Qiao J, Zhou L and Wei J: Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev. 19:CD0041962006.
9	Song W, Li YJ, Qiao X, Qian Y and Ye M: Chemistry of the Chinese herbal medicine Puerariae Radix (Ge-Gen): A review. J Chin Pharm Sci. 23:347–360. 2014. View Article : Google Scholar
10	Chen T, Chen H, Wang Y and Zhang J: In vitro and in vivo antitumour activities of puerarin 6“-O-xyloside on human lung carcinoma A549 cell line via the induction of the mitochondria-mediated apoptosis pathway. Pharm Biol. 54:1793–1799. 2016. View Article : Google Scholar : PubMed/NCBI
11	Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, Guedje NM, Tembe-Fokunang EA, Tomkins P, Barkwan S, Kechia Fz, et al: Traditional medicine: Past, present and future research and development prospects and integration in the national health system of Cameroon. Afr J Tradit Complement Altern Med. 8:284–295. 2011.PubMed/NCBI
12	Xie Q, Yang Y, Wang Z, Chen F, Zhang A and Liu C: Resveratrol-4-O-D-(2′-galloyl)-glucopyranoside isolated from Polygonum cuspidatum exhibits anti-hepatocellular carcinoma viability by inducing apoptosis via the JNK and ERK pathway. Molecules. 19:1592–1602. 2014. View Article : Google Scholar : PubMed/NCBI
13	Mattern J and Volm M: Imbalance of cell proliferation and apoptosis during progression of lung carcinomas. Anticancer Res. 24:4243–4246. 2004.PubMed/NCBI
14	Liu YL, Tang LH, Liang ZQ, You BG and Yang SL: Growth inhibitory and apoptosis inducing by effects of total flavonoids from Lysimachia clethroides Du by in human chronic myeloid leukemia K562 cells. J Ethnopharmacol. 131:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al: Classification of cell death: Recommendations of the nomenclature committee on cell death. Cell Death Differ. 16:3–11. 2009. View Article : Google Scholar : PubMed/NCBI
16	Okada H and Mak TW: Pathways of apoptotic and non-apoptotic death in tumor cells. Nat Rev Cancer. 4:592–603. 2004. View Article : Google Scholar : PubMed/NCBI
17	Yu P, Shi L, Song M and Meng Y: Antitumor activity of paederosidic acid in human non-small cell lung cancer cells via inducing mitochondria-mediated apoptosis. Chem Biol Interact. 269:33–40. 2017. View Article : Google Scholar : PubMed/NCBI
18	Xu J, Jiang S, Li Y, Li M, Cheng Q, Zhao D, Yang B, Jia Z, Wang L and Song L: Caspase-3 serves as an intracellular immune receptor specific for lipopolysaccharide in oyster Crassostrea gigas. Dev Comp Immunol. 61:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
19	Gao N, Budhraja A, Cheng S, Yao H, Zhang Z and Shi X: Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase. Clin Cancer Res. 15:140–149. 2009. View Article : Google Scholar : PubMed/NCBI
20	Yang XK, Xu MY, Xu GS, Zhang YL and Xu ZX: In vitro and in vivo antitumor activity of scutebarbatine A on human lung carcinoma A549 cell lines. Molecules. 19:8740–8751. 2014. View Article : Google Scholar : PubMed/NCBI
21	Peng W, Wu JG, Jiang YB, Liu YJ, Sun T, Wu N and Wu CJ: Antitumor activity of 4-O-(2ˮ-O-acetyl-6ˮ-O-p-coumaroyl-β-D-glucopyranosyl)-p-coumaric acid against lung cancers via mitochondrial-mediated apoptosis. Chem Biol Interact. 233:8–13. 2015. View Article : Google Scholar : PubMed/NCBI
22	Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM and Green DR: Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell. 148:988–1000. 2012. View Article : Google Scholar : PubMed/NCBI
23	Budhraja A, Gao N, Zhang Z, Son YO, Cheng S, Wang X, Ding S, Hitron A, Chen G, Luo J and Shi X: Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol Cancer Ther. 11:132–142. 2012. View Article : Google Scholar : PubMed/NCBI
24	Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene. 48:6245–6251. 2008. View Article : Google Scholar
25	Wang K, Zhang C, Bao J, Jia X, Liang Y, Wang X, Chen M, Su H, Li P, Wan JB and He C: Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep. 6:260642016. View Article : Google Scholar : PubMed/NCBI
26	Jiang Y, Goldberg ID and Shi YE: Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 21:2245–2252. 2002. View Article : Google Scholar : PubMed/NCBI
27	Vihinen P, Ala-aho R and Kähäri VM: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 5:203–220. 2005. View Article : Google Scholar : PubMed/NCBI
28	Luo HZ, Huang ZH, Yu YL, Chen H, Zhou SH and Deng QY: Expression of MMP-9 in colon cancer and its clinical significance. J Oncol. 15:552–553. 2009.
29	Traub S, Morgner J, Martino MM, Höning S, Swartz MA, Wickström SA, Hubbell JA and Eming SA: The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 34:5958–5968. 2013. View Article : Google Scholar : PubMed/NCBI
30	Zhang ZG and Zhu HG: Vascular endothelial growth factor (VEGF) and pancreatic cancer. J Dig Surg. 4:149–151. 2005.